- 全部删除
您的购物车当前为空
Repaglinide (AG-EE 623ZW) 是一种能够用于2 型糖尿病的胰岛素促分泌剂。


为众多的药物研发团队赋能,
让新药发现更简单!
Repaglinide (AG-EE 623ZW) 是一种能够用于2 型糖尿病的胰岛素促分泌剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 133 | In stock | |
| 5 mg | ¥ 192 | In stock | |
| 10 mg | ¥ 263 | In stock | |
| 25 mg | ¥ 413 | In stock | |
| 50 mg | ¥ 595 | In stock | |
| 100 mg | ¥ 997 | In stock | |
| 500 mg | ¥ 2,250 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 275 | In stock |
Repaglinide 相关产品
| 产品描述 | Repaglinide (AG-EE 623ZW) is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury. |
| 体外活性 | 在喂食和饥饿的正常大鼠中,Repaglinide比给予降血糖磺脲类药物后更大更快速地增加血浆胰岛素浓度和较早地下降血糖. |
| 体内活性 | Repaglinide以钙依赖方式结合NCS蛋白质,但不与CAM或S100蛋白结合。Repaglinide以钙依赖方式紧密结合CCaMK和PpCaMK,拮抗结构域的调节功能,对CCaMK和PpCaMK域的IC 50值为55 mM和4 mM。Repaglinide以低亲和力(K(D)= 59 nM)结合单独的SUR1,但以高亲和力结合SUR1与Kir6.2共表达,增加了大约150倍。Repaglinide在视紫红质激酶测定中,拮抗恢复蛋白的抑制作用,IC50值为400 mM。 |
| 别名 | 瑞格列奈, AG-EE 623ZW, AG-EE 388 ZW |
| 分子量 | 452.59 |
| 分子式 | C27H36N2O4 |
| CAS No. | 135062-02-1 |
| Smiles | [C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)(CC(C)C)C2=C(C=CC=C2)N3CCCCC3 |
| 密度 | 1.137g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 84 mg/mL (185.6 mM), Sonication is recommended. DMSO: 55 mg/mL (121.52 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.42 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
| ||||||||||||||||||||||||||||||||||||
评论内容